Justin Walsh
Stock Analyst at Jones Trading
(1.88)
# 3,111
Out of 4,893 analysts
40
Total ratings
38.89%
Success rate
-8.7%
Average return
Main Sectors:
Stocks Rated by Justin Walsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| THTX Theratechnologies | Downgrades: Hold | n/a | $3.16 | - | 3 | Jul 3, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $122 → $109 | $83.83 | +30.03% | 9 | Jun 23, 2025 | |
| VNRX VolitionRx | Initiates: Buy | $3 | $0.66 | +353.86% | 1 | Jun 10, 2025 | |
| BLRX BioLineRx | Upgrades: Buy | $12 | $4.95 | +142.42% | 3 | May 30, 2025 | |
| CLNN Clene | Initiates: Buy | $30 | $3.78 | +693.65% | 1 | Apr 23, 2025 | |
| MNPR Monopar Therapeutics | Downgrades: Hold | n/a | $38.26 | - | 1 | Apr 2, 2025 | |
| SER Serina Therapeutics | Initiates: Buy | $11 | $5.90 | +86.57% | 1 | Mar 11, 2025 | |
| ANRO Alto Neuroscience | Initiates: Buy | $18 | $2.58 | +597.67% | 1 | Dec 16, 2024 | |
| RAPP Rapport Therapeutics | Initiates: Buy | $42 | $15.38 | +173.08% | 1 | Oct 18, 2024 | |
| YMAB Y-mAbs Therapeutics | Initiates: Buy | $23 | $4.53 | +407.73% | 1 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $22 | $4.11 | +435.28% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $5.03 | +218.41% | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $2.33 | +758.37% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $4 | $1.13 | +253.98% | 4 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.69 | +326.44% | 1 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $2.31 | +679.22% | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $440 | $2.00 | +21,900.00% | 1 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $0.35 | +21,267.52% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $20 | $31.33 | -36.16% | 1 | May 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $440 → $200 | $1.90 | +10,426.32% | 2 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.85 | +251.49% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $800 | $5.99 | +13,264.52% | 1 | Sep 2, 2021 |
Theratechnologies
Jul 3, 2025
Downgrades: Hold
Price Target: n/a
Current: $3.16
Upside: -
Lantheus Holdings
Jun 23, 2025
Maintains: Buy
Price Target: $122 → $109
Current: $83.83
Upside: +30.03%
VolitionRx
Jun 10, 2025
Initiates: Buy
Price Target: $3
Current: $0.66
Upside: +353.86%
BioLineRx
May 30, 2025
Upgrades: Buy
Price Target: $12
Current: $4.95
Upside: +142.42%
Clene
Apr 23, 2025
Initiates: Buy
Price Target: $30
Current: $3.78
Upside: +693.65%
Monopar Therapeutics
Apr 2, 2025
Downgrades: Hold
Price Target: n/a
Current: $38.26
Upside: -
Serina Therapeutics
Mar 11, 2025
Initiates: Buy
Price Target: $11
Current: $5.90
Upside: +86.57%
Alto Neuroscience
Dec 16, 2024
Initiates: Buy
Price Target: $18
Current: $2.58
Upside: +597.67%
Rapport Therapeutics
Oct 18, 2024
Initiates: Buy
Price Target: $42
Current: $15.38
Upside: +173.08%
Y-mAbs Therapeutics
Jul 11, 2024
Initiates: Buy
Price Target: $23
Current: $4.53
Upside: +407.73%
May 16, 2024
Maintains: Buy
Price Target: $15 → $22
Current: $4.11
Upside: +435.28%
May 10, 2024
Initiates: Buy
Price Target: $16
Current: $5.03
Upside: +218.41%
Apr 17, 2024
Initiates: Buy
Price Target: $20
Current: $2.33
Upside: +758.37%
Sep 7, 2023
Reinstates: Buy
Price Target: $4
Current: $1.13
Upside: +253.98%
Sep 6, 2023
Initiates: Buy
Price Target: $20
Current: $4.69
Upside: +326.44%
May 16, 2023
Initiates: Buy
Price Target: $18
Current: $2.31
Upside: +679.22%
Feb 10, 2023
Initiates: Buy
Price Target: $440
Current: $2.00
Upside: +21,900.00%
Oct 7, 2022
Initiates: Buy
Price Target: $75
Current: $0.35
Upside: +21,267.52%
May 20, 2022
Maintains: Buy
Price Target: $17 → $20
Current: $31.33
Upside: -36.16%
Apr 5, 2022
Maintains: Buy
Price Target: $440 → $200
Current: $1.90
Upside: +10,426.32%
Jan 19, 2022
Initiates: Buy
Price Target: $10
Current: $2.85
Upside: +251.49%
Sep 2, 2021
Initiates: Buy
Price Target: $800
Current: $5.99
Upside: +13,264.52%